ViaLactia is a leader in global biotechnology-based products, services and technologies for the dairy industry.
Papers and Articles
Marge Will Benefit All Fonterra Shareholders
Opportunities in biofuels and human health for ViaLactia's partners attending BIO2007
'Dairy microbe research points to enzyme future' (the New Zealand Herald)
'Tapping Potential in Plant Genes' (Dairy Exporter magazine)
ViaLactia in 'Industries Of The Future' (Venture magazine)
'Genome Biotechnology - An Option For NZ Dairy Farmers' (Dairy Farmers Conference 2002, Proceedings)
28-May-2007 Marge Will Benefit All Fonterra Shareholders More >>
03-May-2007 Brochure: Identification of Genes for Human Metabolic Disorders using a bovine model system More >>
03-May-2007 Brochure: Novel Enzymes For Improved Ethanol Production From Cellulose More >>